Manorama Industries Limited’s Board of Directors met on September 4, 2026, approving substantial capital infusions into several wholly-owned international subsidiaries. Key approvals include an increase of up to ₹20 crore in Manorama Savanna Ghana Limited and significant capital injections across subsidiaries in Nigeria, Burkina Faso, Chad, Latin America, and UAE, totaling over ₹70 crore. The company also approved the appointment of Dr. Rohini Tiwari as an Additional Director.
Board Approves Key Strategic Decisions
Manorama Industries Limited announced on September 4, 2026, following a Board of Directors meeting, several strategic approvals aimed at expanding its global operations. The meeting, which commenced at 06:00 PM IST and concluded at 07:54 PM IST, covered appointments and substantial financial commitments to its international subsidiaries.
Appointment of Additional Director
The Board approved the appointment of Dr. Rohini Tiwari (DIN:11924749) as an Additional Director in the category of Non-Executive Independent Director. Her tenure will be for a period of 5 consecutive years, effective from September 04, 2026, to September 03, 2031, subject to shareholder approval.
Postal Ballot and E-voting Platform
A cut-off date for sending the Postal Ballot Notice to eligible members was approved. The notice will be sent via email, with a cut-off date of September 11, 2026. Furthermore, the company has engaged MUFG Intime India Private Limited to provide an e-voting facility platform for its members, with voting exclusively through MUFG’s system.
Expansion Through Subsidiary Capital Infusion
The Board also sanctioned significant increases in share capital for several wholly-owned international subsidiaries:
- Manorama Savanna Ghana Limited, Ghana: Up to ₹20 crore.
- Manorama Savanna Limited, Nigeria: Up to ₹10 crore.
- Manorama Burkina SARL, Burkina Faso: Up to ₹15 crore.
- Manorama Savannah Agro Chad Sarl, Republic of Chad: Up to ₹10 crore.
- Manorama Latin America LTDA, Brazil: Up to ₹15 crore.
- Manorama Mena Trading LLC, UAE: Up to ₹5 crore.
These capital infusions are intended for working capital requirements, general corporate purposes, and meeting operational needs, aligning with the companies’ existing business activities and strengthening international operations.
Completion of Tenure
The Board noted the completion of tenure for Mr. Mudit Kumar Singh (DIN: 03276749) as an Independent Director, effective September 05, 2026.
Scrutinizers Appointed
M/s Mehta & Mehta, Company Secretaries, have been appointed as Scrutinizers to conduct the Postal Ballot process.
Source: BSE
